GlassScriptPhysician profile
James Walten Willis
NPI 1417187642
$3,318.05
in general payments reported to CMS, 2019-2025
10 companies · $219 in 2025
The $219 reported for 2025 was more than what 78% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.91 · 2020: $360 · 2021: $32.21 · 2022: $290 · 2023: $1,679 · 2024: $670 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,207 · Education: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,206.55 |
| Education | $362.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,518.35 | 2020-2025 | Invisalign, Itero Element 5d Plus, Itero Element 2 |
| Dentsply Sirona INC | $1,051.62 | 2019-2024 | Trunatomy Rotary File, Waveone Gold Conform Fit |
| Ultradent Products INC | $225.01 | 2019-2024 | |
| Envista Holdings Corporation | $182.75 | 2024 | I-Cat Flx/Flx Mv |
| Straumann USA LLC | $129.49 | 2024 | |
| Nobel Biocare USA | $67.97 | 2023 | Nobelactive |
| Kerr Corporation | $67.97 | 2023 | Harmonize |
| 3m Company | $32.21 | 2021 | |
| Solventum Corporation | $29.53 | 2025 | 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Clinpro, Scotchbond Universal |
| Henry Schein, INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.